IRIS UniCatt

Basso, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.227
AS - Asia 2.008
EU - Europa 1.983
SA - Sud America 336
Continente sconosciuto - Info sul continente non disponibili 104
AF - Africa 65
OC - Oceania 3
Totale 7.726
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.127
SG - Singapore 955
DE - Germania 665
CN - Cina 402
IT - Italia 338
SE - Svezia 315
BR - Brasile 254
VN - Vietnam 233
FR - Francia 135
GB - Regno Unito 91
IN - India 85
FI - Finlandia 84
UA - Ucraina 73
BD - Bangladesh 67
IE - Irlanda 64
CA - Canada 53
ID - Indonesia 50
HK - Hong Kong 45
JP - Giappone 45
RU - Federazione Russa 45
PL - Polonia 39
AR - Argentina 36
TR - Turchia 32
NL - Olanda 27
BE - Belgio 25
MX - Messico 25
CI - Costa d'Avorio 23
EC - Ecuador 18
ES - Italia 18
ZA - Sudafrica 18
IQ - Iraq 16
AT - Austria 15
IR - Iran 13
PK - Pakistan 12
CO - Colombia 11
SA - Arabia Saudita 11
CZ - Repubblica Ceca 8
LT - Lituania 8
VE - Venezuela 7
GR - Grecia 6
KR - Corea 6
CR - Costa Rica 5
RO - Romania 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
MA - Marocco 4
PH - Filippine 4
PY - Paraguay 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
UZ - Uzbekistan 4
AU - Australia 3
CL - Cile 3
JO - Giordania 3
KE - Kenya 3
PE - Perù 3
SN - Senegal 3
SV - El Salvador 3
AL - Albania 2
BY - Bielorussia 2
CH - Svizzera 2
DK - Danimarca 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PT - Portogallo 2
TH - Thailandia 2
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GT - Guatemala 1
HN - Honduras 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
Totale 7.623
Salva come PNG Salva come JPEG
Città #
Ashburn 742
Singapore 607
Chandler 332
San Jose 249
Beijing 83
New York 82
Los Angeles 75
Rome 72
Hanoi 67
Ho Chi Minh City 67
Dublin 63
Ann Arbor 52
San Mateo 52
Wilmington 52
Dallas 51
Helsinki 51
Chicago 49
The Dalles 47
Cattolica 45
Jacksonville 43
Lauterbourg 43
Munich 42
Tokyo 42
Jakarta 41
Nanjing 41
Boston 36
Hong Kong 35
Warsaw 35
Milan 34
Nürnberg 33
Council Bluffs 29
Dearborn 29
Santa Clara 28
Woodbridge 28
Frankfurt am Main 27
Moscow 27
Princeton 27
Fairfield 26
Brussels 24
Houston 24
Matera 24
Abidjan 23
Boardman 22
Orem 22
Shanghai 22
Hefei 21
Hyderabad 21
Nanchang 21
São Paulo 21
Marseille 20
Redwood City 19
Izmir 18
Seattle 18
Denver 17
Montreal 15
Phoenix 15
Augusta 14
Redmond 14
Toronto 14
Atlanta 13
Bremen 13
Buffalo 13
Hangzhou 13
Falls Church 12
Johannesburg 12
Paris 12
Amsterdam 11
Brooklyn 11
Changsha 11
Da Nang 11
Stockholm 11
Chennai 10
Guangzhou 10
Lawrence 10
Leawood 10
Mexico City 10
Newark 10
Nuremberg 10
Poplar 10
Potenza 10
St Louis 10
Turku 10
Guayaquil 9
Hebei 9
Kent 9
London 9
Mountain View 9
Mumbai 9
Norwalk 9
Cambridge 8
Washington 8
Bari 7
Campinas 7
Jeddah 7
Lappeenranta 7
San Francisco 7
Zhengzhou 7
Ankara 6
Dhaka 6
Las Vegas 6
Totale 4.285
Salva come PNG Salva come JPEG
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 619
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 330
A phase II study of sunitinib in advanced hepatocellular carcinoma 281
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 238
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 237
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 215
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 204
Decline of neuroadrenergic bronchial innervation and respiratory function in type 1 diabetes mellitus: a longitudinal study 202
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 199
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 197
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 182
Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma 171
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 164
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases 164
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 163
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 161
Benefit of a multimodal approach combining chemotherapy and surgery in oligometastatic gastric cancer: experience from a tertiary referral center 160
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 160
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients 158
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 152
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 152
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study 150
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 149
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 143
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 143
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 143
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 140
The Impact of a Multidisciplinary Tumor Board (MDTB) in the Management of Colorectal Cancer (CRC) 138
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report 137
Novel epigenetic eight-gene signature predictive of poor prognosis and msi-like phenotype in human metastatic colorectal carcinomas 134
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 132
Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study) 131
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 130
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis. 126
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients 122
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 121
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 119
Operator learning curve for transradial liver cancer embolization: Implications for the initiation of a transradial access program 118
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 109
Lung adenocarcinoma presenting as a solitary gingival metastasis: a case report 105
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 105
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 103
Treatment of locally advanced gastric cancer (LAGC): Back to lauren’s classification in pan– cancer analysis era? 92
Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study 89
Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse 88
The interference between oxaliplatin & anti-EGFR therapies: A different hypothesis to explain the 'unexplainable' 87
Targeted therapy in advanced gastric carcinoma: The future is beginning 76
New life for retrospective study in the precision oncology era 68
Molecular and Clinical Profile of a RET-Rearranged Colorectal Cancer With Prolonged Response to Platinum Therapy and Subsequent Targeted Treatment With Selpercatinib 19
Totale 7.726
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.291
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.291
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022400 0 0 12 64 27 11 7 68 17 37 61 96
2022/2023926 124 125 82 168 42 108 48 76 75 25 32 21
2023/2024862 20 90 28 14 12 71 236 263 2 16 38 72
2024/2025862 16 39 71 37 76 37 33 37 93 96 166 161
2025/20263.034 334 87 187 447 636 155 480 137 195 155 101 120
2026/2027210 70 109 31 0 0 0 0 0 0 0 0 0
Totale 7.726